The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera.
暂无分享,去创建一个
W. Vainchenker | S. Koscielny | C. James | V. Ugo | F. Delhommeau | N. Casadevall | Y. Lécluse | P. Saulnier | S. Dupont | A. Massé | J. L. Le Couédic | I. Teyssandier | F. Larbret